No. of patients |
101 |
27 |
128 |
|
|
Age |
41.22 ± 14.60 |
54.59 ± 9.96 |
44.04 ± 14.77 |
−5.564 |
<0.001 |
Gender |
|
|
|
|
|
Female |
40 |
5 |
45 |
4.155 |
0.042 |
Male |
61 |
22 |
83 |
|
|
Fracture classification |
|
|
|
|
|
Tile A |
5 |
1 |
6 |
7.127 |
0.028 |
Tile B |
61 |
9 |
70 |
|
|
Tile C |
35 |
17 |
52 |
|
|
Medical morbidity |
|
|
|
|
|
Hypertension |
2 |
6 |
8 |
0.000 |
1.000 |
Diabetes |
2 |
1 |
3 |
0.000 |
1.000 |
Coronary heart disease |
4 |
1 |
5 |
0.000 |
1.000 |
Arrhythmia |
3 |
1 |
4 |
0.000 |
1.000 |
Associated trauma |
38 |
13 |
51 |
0.985 |
0.321 |
History of tumor |
1 |
0 |
1 |
0.000 |
1.000 |
Preoperative blood transfusion |
29 |
12 |
41 |
2.422 |
0.120 |
BMI |
21.99 ± 3.48 |
21.35 ± 3.46 |
21.86 ± 3.47 |
0.848 |
0.398 |
Days between fracture and hospitalization (days) |
3.76 ± 5.05 [0,30] |
3.81 ± 4.75 [0,18] |
3.77 ± 4.97 [0,30] |
−0.048 |
0.961 |
Days between fracture and operation (days) |
9.15 ± 5.71 |
9.22 ± 5.05 |
9.16 ± 5.56 |
−0.061 |
0.951 |
ASA classification |
|
|
|
|
|
1 |
21 |
2 |
23 |
10.761 |
0.013 |
2 |
56 |
10 |
66 |
|
|
3 |
23 |
14 |
37 |
|
|
4 |
1 |
1 |
2 |
|
|
Serum markers |
|
|
|
|
|
HGB at admission (mg/L) |
112.26 ± 19.86 |
106.46 ± 24.38 |
111.02 ± 20.93 |
1.256 |
0.212 |
HCT at admission (%) |
34.43 ± 9.13 |
32.15 ± 7.98 |
33.95 ± 8.92 |
1.158 |
0.249 |
HGB at preoperative 1 day (mg/L) |
112.03 ± 17.93 |
105.50 ± 14.40 |
110.56 ± 17.323 |
1.335 |
0.186 |
HCT at preoperative 1 day (%) |
34.03 ± 4.20 |
32.36 ± 4.05 |
33.65 ± 4.20 |
1.413 |
0.162 |
D-dimer at admission (mg/L) |
10.11 ± 11.91 [0.80,62.60] |
20.31 ± 16.83 [4.05,71.09] |
12.24 ± 13.66 [0.80,71.09] |
−3.475 |
0.001 |
FIB at admission (mg/L) |
4.38 ± 4.27 [1.45,32.10] |
3.32 ± 1.33 [1.47,5.95] |
4.16 ± 3.87 [1.45,32.10] |
1.219 |
0.225 |
D-dimer at preoperative 1 day (mg/L) |
8.09 ± 7.13 [0.79,32.50] |
12.25 ± 17.14 [3.08,69.56] |
9.34 ± 11.08 [0.79,69.56] |
−0.906 |
0.378 |